Weight Loss

Biography

Biography: Vera Simovska-Jarevska

Abstract

Obesity is a chronic disease that increase the risk for coronary heart disease (CHD), type II diabetes (T2DM) and certain types of cancer, some of the leading causes of preventable death. It’s a growing public health problem worldwide. The purpose of our study was to develop a model of therapeutic efficiency high-intensity lifestyle intervention intended for truncal obese adults with increased cardiometabolic risk. Within the randomised controled trial at a group of truncal obese adults with risk factors for CHD and T2DM, we suggest the following two types of high-intensity lifestyle interventions: Ist-low fat, moderate hyperprotein, restriction diet (RD) of 1200-kcal/d(female) and 1500-kcal/d(male) with low atherogenic and glycemic(GI) index, and a specific proportion among SFA, MUFA and PUFA. The IInd-RD and the individually dosed physical activty (PA) with gradually, from low to modetare and peaks of high intensity (50%-60%-75%VO2max) in accordance to the initial level of the individual aerobic capacity (VO2max), expresed into METs. After 30 days was the increased energetic value of RD for 200-kcal/d in accordance with increased PA. The changes in anthropometric measures, metabolic profiles, VO2max and BMR are evaluated after 30 and 50days. The efficiency of the progammed PA in combination with RD represenets a significant higher reduction of BMI (kg/m2), WHR, fat mass index, risk factors for CHD and metabolic complication (hyperglycemia, dyslipidemia, arterial hypertension and atherogenic indexes) associated with truncal obesity and significant improvement in cardiorespiratory fitness for 17.16% VO2max from initial level. However, weight loss is influenced by individual biology and due to metabolic differences. European qudeline on prevention and management for nutritionists/dietitians by EFAD (ESDN Obesity) is desirable.